An upcoming IPWatchdog webinar will address the intersection of intellectual property law with drug repurposing and diagnostics during the COVID-19 pandemic. The event comes as the virus continues to infect prominent figures and strain hospitals, highlighting the need for rapid therapeutic and testing solutions.
The webinar's focus on drug repurposing and diagnostics reflects a broader policy debate: how IP rights can both incentivize innovation and create barriers to access. While the announcement does not detail specific legal arguments, it signals that the discussion will cover the balance between patent protections and public health needs.
Given the scale of the crisis, the session is likely to be of interest to patent attorneys, policymakers, and healthcare stakeholders. The source is a single event announcement, so the article does not provide substantive analysis, but it frames the legal questions that will be explored.